Small Molecules

We bring together three experts to discuss how we can protect medicine makers in a world of increasingly powerful drugs.

Click chemistry creates biocompatible hydrogels for drug delivery and tissue engineering

Dr Paul Kippax is looking at how recent innovations are enhancing the value and informational productivity of some of our analytical techniques.

Progress is too often hampered by our inability to gather the information needed to make advances.

Sitting Down With... Dirk Sauer, Novartis’ Global Head, Development Franchise Ophthalmics.

Will bacteriophages be the savior of the human race in the post-antibiotic era or is it just pie in the sky?

By mimicking natural evolution of enzymes, researchers are creating biocatalysts for reactions unheard of in nature.

What impact will genetic changes have on new medicines currently in development?

By eliminating protein A, researchers aim to deliver continuous processing at a fraction of the cost of conventional techniques.

The industry has been dipping its toe into the water of continuous manufacturing for years.